ICU Medical (ICUI) Price & Analysis

Compare

198 Followers

ICUI Stock Chart & Stats

Day’s Range― - ―

52-Week Range$117.92 - $196.26

Previous CloseN/A

Volume45.78K

Average Volume (3M)200.29K

Market Cap

$3.12B

Enterprise ValueN/A

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta0.94

Next Earnings

Aug 07, 2025

EPS Estimate

1.5

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)1.72

Shares Outstanding24,611,937

10 Day Avg. Volume167,622

30 Day Avg. Volume200,294

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)0.00

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

$189.00

Price Target Upside47.18% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering3

Bulls Say, Bears Say

Bulls Say

Financial PerformanceICUI's 1Q25 revenue, EBITDA, and EPS beat consensus.

PartnershipsICUI's partnership with Otsuka is expected to boost both revenue growth and margin profile, supporting a higher valuation.

Revenue GrowthRevenue growth improved to 10% CC in 1Q25 from 7% CC in 4Q24, driven by Consumables and Infusion Systems.

Bears Say

Profitability ConcernsMargin outlook was addressed, suggesting some concerns about profitability.

Tariff ImpactICUI expects a $25-30M tariff impact mostly in 2H25 but expects more favorable currency rates and mitigation efforts to reduce this to $5-10M of unmitigated residual impact.

Valuation ConcernsICUI's valuation is well above peers with similar organic growth rates.

ICU Medical News

ICU Medical Stockholders Approve Key Proposals at Meeting

ICU Medical ( ($ICUI) ) has provided an update. On May 13, 2025, ICU Medical, Inc. held its...

3M ago

ICUI

ICU Medical Balances Growth and Challenges in Earnings Call

ICU Medical (($ICUI)) has held its Q1 earnings call. Read on for the main highlights of the call....

3M ago

ICUI

ICU Medical price target lowered to $187 from $197 at Raymond James

Raymond James lowered the firm’s price target on ICU Medical (ICUI) to $187 from $197 and keeps a...

3M ago

ICUI

ICU Medical Reports Strong Q1 2025 Revenue Growth

ICU Medical ( ($ICUI) ) has released its Q1 earnings. Here is a breakdown of the information ICU...

3M ago

ICUI

ICU Medical reports Q1 adjusted EPS $1.72, consensus $1.28

Reports Q1 revenue $604.702M, consensus $574.15M Published first on TheFly – the ultimate source for real-time, market-moving breaking...

3M ago

ICUI

ICU Medical (ICUI) Q1 Earnings Cheat Sheet

ICU Medical (ICUI) is scheduled to report 1st quarter earnings on 05/08/2025, after the market closes. Regarding Q1...

3M ago

ICUI

ICU Medical price target lowered to $191 from $209 at KeyBanc

KeyBanc analyst Brett Fishbin lowered the firm’s price target on ICU Medical (ICUI) to $191 from $209 and...

3M ago

ICUI

ICU Medical announces FDA 510(k) clearance for Plum Solo, Plum Duo pumps

ICU Medical (ICUI) has announced 510(k) regulatory clearance from the U.S. FDA for the Plum Solo precision IV...

4M ago

ICUI

ICU Medical added to Analyst Current Favorites list at Raymond James

Raymond James added ICU Medical (ICUI) to the firm’s Analyst Current Favorites list. The list contains the current...

5M ago

ICUI

ICU Medical upgraded to Strong Buy from Outperform at Raymond James

Raymond James upgraded ICU Medical (ICUI) to Strong Buy from Outperform with a price target of $97, down...

5M ago

ICUI

ICU Medical’s Earnings Call: Growth Amid Challenges

ICU Medical (($ICUI)) has held its Q4 earnings call. Read on for the main highlights of the call....

5M ago

ICUI

ICU Medical Reports Revenue Growth Amid Net Loss

ICU Medical ( ($ICUI) ) has released its Q4 earnings. Here is a breakdown of the information ICU...

5M ago

ICUI

ICU Medical reports Q4 EPS $2.11, consensus $1.48

Reports Q4 revenue $629.8M, consensus $599.1M. Adjusted EBITDA was $105.5 million for the fourth quarter of 2024 as...

5M ago

ICUI

ICU Medical sees FY25 EPS $6.55-$7.25, consensus $7.13

For fiscal year 2025 the Company estimates GAAP net loss to be in the range of $(45) million...

5M ago

ICUI

ICUI FAQ

What was Icu Medical’s price range in the past 12 months?

Icu Medical lowest stock price was $117.92 and its highest was $196.26 in the past 12 months.

What is Icu Medical’s market cap?

Icu Medical’s market cap is $3.12B.

When is Icu Medical’s upcoming earnings report date?

Icu Medical’s upcoming earnings report date is Aug 07, 2025 which is in 5 days.

How were Icu Medical’s earnings last quarter?

Icu Medical released its earnings results on May 08, 2025. The company reported $1.72 earnings per share for the quarter, beating the consensus estimate of $1.28 by $0.44.

Is Icu Medical overvalued?

According to Wall Street analysts Icu Medical’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Icu Medical pay dividends?

Icu Medical does not currently pay dividends.

What is Icu Medical’s EPS estimate?

Icu Medical’s EPS estimate is 1.5.

How many shares outstanding does Icu Medical have?

Icu Medical has 24,611,937 shares outstanding.

What happened to Icu Medical’s price movement after its last earnings report?

Icu Medical reported an EPS of $1.72 in its last earnings report, beating expectations of $1.28. Following the earnings report the stock price went down -3.199%.

Which hedge fund is a major shareholder of Icu Medical?

Currently, no hedge funds are holding shares in ICUI

ICU Medical Stock Smart Score

Underperform

Fundamentals

Return on Equity

-4.62%

Trailing 12-Months

Asset Growth

-2.42%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Icu Medical

ICU Medical, Inc. (ICUI) is a healthcare company specializing in the development, manufacturing, and sale of innovative medical devices and systems for infusion therapy, oncology, and critical care applications. The company's core products include IV therapy systems, needle-free connectors, closed system transfer devices, and other related accessories. ICU Medical serves hospitals, healthcare facilities, and other medical institutions across the globe, focusing on improving patient safety and enhancing clinical outcomes.

ICU Medical (ICUI) Earnings & Revenues

ICUI Earnings Data >

ICUI Company Deck

ICUI Earnings Call

Q1 2025

0:00 / 0:00

Earnings Call Sentiment|Neutral

ICU Medical's earnings call reflected both positive and negative aspects. The company demonstrated strong revenue growth and effectively managed debt repayment while forming a promising joint venture. However, significant challenges include the impact of tariffs, regulatory issues, and a cautious outlook on guidance. The sentiment is balanced, with highlights and lowlights having a comparable weight.Read More>

ICUI Stock 12 Month Forecast

Average Price Target

$189.00

▲(47.18%Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"91":"$91","192":"$192","116.25":"$116.3","141.5":"$141.5","166.75":"$166.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":191,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$191.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":189,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$189.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":187,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$187.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[91,116.25,141.5,166.75,192],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Nov<br/>2024","9":"Mar<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,134.95,139.26153846153846,143.5730769230769,147.8846153846154,152.19615384615383,156.5076923076923,160.81923076923076,165.13076923076923,169.44230769230768,173.75384615384615,178.0653846153846,182.37692307692308,186.68846153846152,{"y":191,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,134.95,139.1076923076923,143.26538461538462,147.4230769230769,151.58076923076922,155.73846153846154,159.89615384615385,164.05384615384617,168.21153846153845,172.36923076923077,176.52692307692308,180.68461538461537,184.8423076923077,{"y":189,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,134.95,138.95384615384614,142.9576923076923,146.96153846153845,150.9653846153846,154.96923076923076,158.97307692307692,162.97692307692307,166.98076923076923,170.98461538461538,174.98846153846154,178.9923076923077,182.99615384615385,{"y":187,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":92.88,"date":1706745600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":98.29,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":106.34,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":126.25,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":165.33,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":179.14,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":170.82,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":160.96,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":164.36,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":146.33,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":137.8,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":136.97,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":134.95,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >